Consumer Health COVID19
Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization ...
March 21, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
March 11, 2022 | News
Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today, announced the CE-IVD marking of its Allplex™ SARS-CoV...
February 25, 2022 | News
According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...
February 21, 2022 | News
"The TGA authorization for the use of our COVID-19 vaccine in children 6-11 years old in Australia is an important milestone for Moderna as it is the first...
February 18, 2022 | News
The BUZUD HFNC is approved by Singapore’s Health Sciences Authority (HSA) and provides adequately heated and humidified respiratory gases to spontane...
February 16, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 15, 2022 | News
Hong Kong has been severely hit by the latest wave of COVID-19 infections in recent weeks. In response to challenges including the lack of manpower fo...
February 15, 2022 | News
- Seegene to sign a contract with the Brazilian government to supply 4 million COVID-19 tests and associated consumables - 'Allplex™ SARS-CoV-2/FluA...
February 14, 2022 | News
Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...
February 14, 2022 | News
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...
February 08, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 04, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 01, 2022 | News
The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people aged 16–17 years old. The adv...
January 31, 2022 | News
Most Read
Bio Jobs
News